FDA Approves New HIV Treatment for Patients With Limited Treatment Options | HIV.gov

FDA Approves New HIV Treatment for Patients With Limited Treatment Options | HIV.gov

FDA Approves New HIV Treatment for Patients With Limited Treatment Options

[On July 2, 2020], the U.S. Food and Drug Administration approved Rukobia (fostemsavir), a new type of antiretroviral medication for adults living with HIV who have tried multiple HIV medications and whose HIV infection cannot be successfully treated with other therapies because of resistance, intolerance or safety considerations.

LEARN MORE